Open access · CC-BY
via OpenAlex
Telomerase Inhibitors and Activators: Pharmaceutical Importance
InTech eBooks · 2017 · ▲ 6 citations
Abstract
Telomeres are specialized functional complexes that protect the ends of eukaryotic chromosomes. The telomeric DNA sequences are tandem repeats of a short hexameric sequence unit. The inability to DNA polymerase to replicate the end of the chromosome during lagging strand synthesis results in the loss of telomeric repeats when cell divides. Telomere(definition) shortening provides a barrier to cancer progression and the majority of the cancer cells depend on the activation of telomerase to gain proliferative immortality. Thus, telomerase is a molecular target for diseases since its discovery. Telomerase inhibition enables more specific ground for cancer therapy because the telomerase is not detected in most normal tissues. Some of the synthetic and natural telomerase inhibitors were tried on various cancer cells and there was a decrease in the number of cancer cells. But on the other hand, telomere shortening correlates with cellular aging. Some evidence suggests that the progressive loss of telomeric repeats of chromosomes may function as a molecular clock that triggers senescence(definition). Telomerase-related gene mutations also result in some diseases. Because of this, telomerase activators are important for antiaging and telomerase-dependent disease treatments. This chapter summarizes the pharmaceutical importance of telomeres, telomerase structure, telomerase activators, and inhibitors.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5772/65933
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Mutlu, A.G. (2017). Telomerase Inhibitors and Activators: Pharmaceutical Importance. <em>InTech eBooks</em>. https://doi.org/10.5772/65933
Vancouver
Mutlu AG. Telomerase Inhibitors and Activators: Pharmaceutical Importance. InTech eBooks. 2017. doi:10.5772/65933.
BibTeX
@article{aye2017Telome,
title = {Telomerase Inhibitors and Activators: Pharmaceutical Importance},
author = {Ayşe Gül Mutlu},
journal = {InTech eBooks},
year = {2017},
doi = {10.5772/65933},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinics 2021
Open access · CC-BY
Telomere Attrition and p53 Response 1 (TAPR1): a new player in cancer biology?
Journal of Biological Chemistry 2009
Open access · CC-BY
Chromosome End Maintenance by Telomerase
Nucleic Acids Research 2002
Open access · OA
Natural and pharmacological regulation of telomerase
Mini-Reviews in Organic Chemistry 2016
Citation only
Telomerase Inhibitors: Potential Anticancer Agents
Journal of Urological Surgery 2016
Open access · CC-BY
Re: Role of Telomeres and Telomerase in Cancer
PubMed 1996
Preprint